Arcadis NV (AMS:ARCAD)
41.30
-0.96 (-2.27%)
Aug 6, 2025, 5:35 PM CET
Verve Therapeutics Market Cap
Arcadis NV has a market cap or net worth of €3.79 billion as of August 6, 2025. Its market cap has decreased by -35.55% in one year.
Market Cap
3.79B
Enterprise Value
4.83B
Revenue
4.94B
Ranking
n/a
PE Ratio
15.94
Stock Price
$41.30
Market Cap Chart
Since April 1, 1998, Arcadis NV's market cap has increased from 208.17M to 3.79B, an increase of 1,719.43%. That is a compound annual growth rate of 11.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 3.70B | -29.95% |
Dec 31, 2024 | 5.28B | 20.27% |
Dec 29, 2023 | 4.39B | 33.67% |
Dec 30, 2022 | 3.29B | -12.00% |
Dec 31, 2021 | 3.74B | 53.64% |
Dec 31, 2020 | 2.43B | 31.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Wolters Kluwer | 30.85B |
Exor N.V. | 17.40B |
Randstad | 7.08B |
InPost | 6.25B |
Aalberts | 3.02B |
Signify | 2.58B |
Koninklijke BAM Groep nv | 1.96B |
Theon International | 1.77B |